CLINICAL_TRIALS
trial_result
· 2023-12-07
Clinical Trial Update: NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
Summary
A completed all-case surveillance trial evaluating NINLARO (ixazomib) capsules for relapsed/refractory multiple myeloma with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Relapsed/Refractory Multiple Myeloma | Status: COMPLETED | Results posted: 2023-12-07